EcoDrugPlus

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSHBUG00000012210
Gene Symbol: LOC102303370
3 Cross references
206 Possible Orthologues:

Uncharacterized Loc102298892

Ensembl ID : ENSHBUG00000008667
Gene Symbol: LOC102298892
2 Cross references
194 Possible Orthologues:

Uncharacterized Loc102310023

Ensembl ID : ENSHBUG00000022381
Gene Symbol: LOC102310023
2 Cross references
196 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSHBUG00000004600
Gene Symbol: UTS2R
4 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSHBUG00000008972
Gene Symbol: UTRN
2 Cross references
269 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSHBUG00000014668
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSHBUG00000012686
Gene Symbol: VDR
3 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSHBUG00000023547
Gene Symbol: LOC102308656
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSHBUG00000003442
Gene Symbol: LOC102300716
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d-Like

Ensembl ID : ENSHBUG00000020008
Gene Symbol: LOC102306209
3 Cross references
177 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d-Like

Ensembl ID : ENSHBUG00000017225
Gene Symbol: LOC102296884
3 Cross references
211 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-1-Like

Ensembl ID : ENSHBUG00000007270
Gene Symbol: LOC102309698
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).